Sarepta Therapeutics, Inc.

SRPT

—

Advanced chart & tools →

Sarepta Therapeutics, Inc.SRPT

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-7.13

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$1.86B

Net income

$-713.41M

Net margin

-38.3%

Gross margin

-1.6%

Dividends & financials

Sarepta Therapeutics, Inc. (SRPT) reported revenue of $1.86B and net income of $-713.41M, or $-7.13 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.